Stay updated with breaking news from Markl Baum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
18.07.2023 - Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the signing of agreements with affiliates of Santen Pharmaceutical Co., Ltd. (“Santen”) under which Harrow will acquire certain U.S. and Canadian commercial rights ... Seite 1
HROW | Complete Harrow Health Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Operator: Good afternoon, and welcome to Harrow's First Quarter 2023 Earnings Conference Call. My name is Joe, and I will be your operator for today's call.
The pharmaceutical company announced first-quarter earnings Thursday afternoon.
Harrow, a leading U.S. eyecare pharmaceutical company, entered into a $100 million secured credit financing agreement with funds managed by Oaktree Capital Management. The interest-only secured credit facility carries an interest rate equal to the three-month secured overnight financing rate (SOFR) plus 6.50%, includes flexible terms and covenants...